REMX vs. RARE
Compare and contrast key facts about VanEck Vectors Rare Earth/Strategic Metals ETF (REMX) and Ultragenyx Pharmaceutical Inc. (RARE).
REMX is a passively managed fund by VanEck that tracks the performance of the MVIS Global Rare Earth/Strategic Metals Index. It was launched on Oct 27, 2010.
Performance
REMX vs. RARE - Performance Comparison
Loading graphics...
REMX vs. RARE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
REMX VanEck Vectors Rare Earth/Strategic Metals ETF | 19.05% | 92.95% | -35.02% | -19.18% | -31.13% | 79.81% | 64.82% | 0.74% | -49.63% | 82.60% |
RARE Ultragenyx Pharmaceutical Inc. | -8.91% | -45.33% | -12.02% | 3.22% | -44.90% | -39.25% | 224.12% | -1.77% | -6.25% | -34.03% |
Returns By Period
In the year-to-date period, REMX achieves a 19.05% return, which is significantly higher than RARE's -8.91% return. Over the past 10 years, REMX has outperformed RARE with an annualized return of 10.24%, while RARE has yielded a comparatively lower -10.90% annualized return.
REMX
- 1D
- 2.95%
- 1M
- -11.88%
- YTD
- 19.05%
- 6M
- 36.14%
- 1Y
- 126.68%
- 3Y*
- 4.04%
- 5Y*
- 5.20%
- 10Y*
- 10.24%
RARE
- 1D
- 8.55%
- 1M
- -10.43%
- YTD
- -8.91%
- 6M
- -30.35%
- 1Y
- -42.14%
- 3Y*
- -19.46%
- 5Y*
- -28.64%
- 10Y*
- -10.90%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
REMX vs. RARE — Risk / Return Rank
REMX
RARE
REMX vs. RARE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Rare Earth/Strategic Metals ETF (REMX) and Ultragenyx Pharmaceutical Inc. (RARE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| REMX | RARE | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.65 | -0.59 | +3.23 |
Sortino ratioReturn per unit of downside risk | 3.08 | -0.42 | +3.49 |
Omega ratioGain probability vs. loss probability | 1.39 | 0.93 | +0.46 |
Calmar ratioReturn relative to maximum drawdown | 5.10 | -0.81 | +5.91 |
Martin ratioReturn relative to average drawdown | 15.16 | -1.53 | +16.68 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| REMX | RARE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.65 | -0.59 | +3.23 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.13 | -0.53 | +0.66 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.28 | -0.20 | +0.48 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.10 | -0.10 | 0.00 |
Correlation
The correlation between REMX and RARE is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
REMX vs. RARE - Dividend Comparison
REMX's dividend yield for the trailing twelve months is around 1.48%, while RARE has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
REMX VanEck Vectors Rare Earth/Strategic Metals ETF | 1.48% | 1.76% | 2.56% | 0.00% | 1.56% | 5.25% | 0.81% | 1.64% | 12.43% | 2.89% | 2.23% | 4.77% |
RARE Ultragenyx Pharmaceutical Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
REMX vs. RARE - Drawdown Comparison
The maximum REMX drawdown since its inception was -90.20%, roughly equal to the maximum RARE drawdown of -89.57%. Use the drawdown chart below to compare losses from any high point for REMX and RARE.
Loading graphics...
Drawdown Indicators
| REMX | RARE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.20% | -89.57% | -0.63% |
Max Drawdown (1Y)Largest decline over 1 year | -23.35% | -55.36% | +32.01% |
Max Drawdown (5Y)Largest decline over 5 years | -73.34% | -84.01% | +10.67% |
Max Drawdown (10Y)Largest decline over 10 years | -73.34% | -89.57% | +16.23% |
Current DrawdownCurrent decline from peak | -59.70% | -88.19% | +28.49% |
Average DrawdownAverage peak-to-trough decline | -67.01% | -54.28% | -12.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.86% | 29.21% | -21.35% |
Volatility
REMX vs. RARE - Volatility Comparison
The current volatility for VanEck Vectors Rare Earth/Strategic Metals ETF (REMX) is 17.39%, while Ultragenyx Pharmaceutical Inc. (RARE) has a volatility of 18.67%. This indicates that REMX experiences smaller price fluctuations and is considered to be less risky than RARE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| REMX | RARE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.39% | 18.67% | -1.28% |
Volatility (6M)Calculated over the trailing 6-month period | 37.90% | 67.87% | -29.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 48.30% | 71.96% | -23.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.76% | 54.11% | -14.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.61% | 55.61% | -19.00% |